A Study to Test if TEV-53275 is Effective in Relieving Asthma
Public ClinicalTrials.gov record NCT04847674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Assess the Safety, Efficacy and Pharmacodynamics of TEV 53275 Administered Subcutaneously in Adult Patients With Persistent Eosinophilic Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study is to evaluate the efficacy of TEV-53275 administered subcutaneously (sc) in adult participants with persistent asthma and an eosinophilic phenotype compared to placebo. A secondary objective is to evaluate the efficacy of TEV-53275 compared to placebo assessed by lung function, asthma symptoms, rescue medication use, and quality of life measures. Another secondary objective is to evaluate the safety and tolerability of TEV-53275 administered sc in adult participants with persistent asthma and an eosinophilic phenotype compared with placebo, and lastly, to evaluate the immunogenicity of TEV-53275 administered sc in adult participants with persistent asthma and an eosinophilic phenotype.
Study identification
- NCT ID
- NCT04847674
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 97 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 3, 2021
- Primary completion
- Apr 27, 2022
- Completion
- Apr 27, 2022
- Last update posted
- Jun 7, 2023
2021 – 2022
United States locations
- U.S. sites
- 77
- U.S. states
- 25
- U.S. cities
- 65
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 15188 | Hoover | Alabama | 35244 | — |
| Teva Investigational Site 15174 | Peoria | Arizona | 85381 | — |
| Teva Investigational Site 15202 | Phoenix | Arizona | 85031 | — |
| Teva Investigational Site 15205 | Tucson | Arizona | 85712 | — |
| Teva Investigational Site 15178 | Bakersfield | California | 93301 | — |
| Teva Investigational Site 15196 | Bakersfield | California | 93309 | — |
| Teva Investigational Site 15176 | Encinitas | California | 92024 | — |
| Teva Investigational Site 15156 | Huntington Beach | California | 92647 6818 | — |
| Teva Investigational Site 15209 | Inglewood | California | 90303 | — |
| Teva Investigational Site 15194 | Los Angeles | California | 90017 | — |
| Teva Investigational Site 15143 | Los Angeles | California | 90025 | — |
| Teva Investigational Site 15212 | Los Angeles | California | 91436 | — |
| Teva Investigational Site 15151 | Mission Viejo | California | 92691 | — |
| Teva Investigational Site 15210 | North Hollywood | California | 91606 | — |
| Teva Investigational Site 15136 | San Jose | California | 95117 | — |
| Teva Investigational Site 15157 | Stockton | California | 95207 | — |
| Teva Investigational Site 15158 | Upland | California | 91786 | — |
| Teva Investigational Site 15167 | Walnut Creek | California | 94598 | — |
| Teva Investigational Site 15133 | Westminster | California | 92683 | — |
| Teva Investigational Site 15166 | Colorado Springs | Colorado | 80907 | — |
| Teva Investigational Site 15200 | Lafayette | Colorado | 80026 | — |
| Teva Investigational Site 15139 | Wheat Ridge | Colorado | 80033 | — |
| Teva Investigational Site 15182 | Boynton Beach | Florida | 33435 | — |
| Teva Investigational Site 15147 | Hialeah | Florida | 33012 | — |
| Teva Investigational Site 15134 | Hialeah | Florida | 33016 | — |
| Teva Investigational Site 15152 | Leesburg | Florida | 34748 | — |
| Teva Investigational Site 15149 | Miami | Florida | 33144 | — |
| Teva Investigational Site 15211 | Miami | Florida | 33155 | — |
| Teva Investigational Site 15206 | Miami | Florida | 33165 | — |
| Teva Investigational Site 15215 | Miami | Florida | 33165 | — |
| Teva Investigational Site 15141 | Miami | Florida | 33173 | — |
| Teva Investigational Site 15169 | Miami Lakes | Florida | 33014 | — |
| Teva Investigational Site 15170 | North Palm Beach | Florida | 33408 | — |
| Teva Investigational Site 15130 | Orlando | Florida | 32819 | — |
| Teva Investigational Site 15140 | Tallahassee | Florida | 32308-4355 | — |
| Teva Investigational Site 15132 | Tampa | Florida | 33607 | — |
| Teva Investigational Site 15135 | Sugar Hill | Georgia | 30518 | — |
| Teva Investigational Site 15183 | Normal | Illinois | 61761 | — |
| Teva Investigational Site 15198 | Overland Park | Kansas | 66210 | — |
| Teva Investigational Site 15187 | Zachary | Louisiana | 70791 | — |
| Teva Investigational Site 15148 | Baltimore | Maryland | 21236 | — |
| Teva Investigational Site 15190 | North Dartmouth | Massachusetts | 02747 | — |
| Teva Investigational Site 15175 | Columbia | Missouri | 65203 | — |
| Teva Investigational Site 15145 | Rolla | Missouri | 65401 | — |
| Teva Investigational Site 15144 | St Louis | Missouri | 63141 | — |
| Teva Investigational Site 15137 | Bellevue | Nebraska | 68123-4303 | — |
| Teva Investigational Site 15164 | Skillman | New Jersey | 08558 | — |
| Teva Investigational Site 15165 | The Bronx | New York | 10455 | — |
| Teva Investigational Site 15181 | Charlotte | North Carolina | 28277 | — |
| Teva Investigational Site 15179 | Elizabeth City | North Carolina | 27909 | — |
| Teva Investigational Site 15193 | Greensboro | North Carolina | 27410 | — |
| Teva Investigational Site 15153 | Monroe | North Carolina | 28112 | — |
| Teva Investigational Site 15168 | Raleigh | North Carolina | 27607 | — |
| Teva Investigational Site 15173 | Cincinnati | Ohio | 45231 | — |
| Teva Investigational Site 15131 | Toledo | Ohio | 43617 | — |
| Teva Investigational Site 15201 | Edmond | Oklahoma | 73034 | — |
| Teva Investigational Site 15204 | Tulsa | Oklahoma | 74133 | — |
| Teva Investigational Site 15180 | Medford | Oregon | 97504 | — |
| Teva Investigational Site 15172 | Portland | Oregon | 97239 | — |
| Teva Investigational Site 15192 | Jenkintown | Pennsylvania | 19046 | — |
| Teva Investigational Site 15185 | Pittsburgh | Pennsylvania | 15241 | — |
| Teva Investigational Site 15161 | Clinton | South Carolina | 29325 | — |
| Teva Investigational Site 15159 | Rock Hill | South Carolina | 29732 | — |
| Teva Investigational Site 15162 | Austin | Texas | 78759 | — |
| Teva Investigational Site 15138 | Dallas | Texas | 75231 | — |
| Teva Investigational Site 15154 | Dallas | Texas | 75231 | — |
| Teva Investigational Site 15171 | Denton | Texas | 76210 | — |
| Teva Investigational Site 15155 | El Paso | Texas | 79903-3508 | — |
| Teva Investigational Site 15189 | Houston | Texas | 77030 | — |
| Teva Investigational Site 15184 | Houston | Texas | 77070 | — |
| Teva Investigational Site 15199 | Houston | Texas | 77084 | — |
| Teva Investigational Site 15191 | Houston | Texas | 77087 | — |
| Teva Investigational Site 15160 | McKinney | Texas | 75069 | — |
| Teva Investigational Site 15197 | San Antonio | Texas | 78258 | — |
| Teva Investigational Site 15195 | Williamsburg | Virginia | 23188 | — |
| Teva Investigational Site 15150 | Bellingham | Washington | 98225 | — |
| Teva Investigational Site 15142 | Greenfield | Wisconsin | 53228 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04847674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2023 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04847674 live on ClinicalTrials.gov.